SiBone (NASDAQ:SIBN – Get Free Report) and Innovative Eyewear (NASDAQ:LUCY – Get Free Report) are both small-cap healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, risk, profitability, earnings, dividends, analyst recommendations and valuation.
Risk & Volatility
SiBone has a beta of 0.7, suggesting that its stock price is 30% less volatile than the S&P 500. Comparatively, Innovative Eyewear has a beta of 2.76, suggesting that its stock price is 176% more volatile than the S&P 500.
Valuation and Earnings
This table compares SiBone and Innovative Eyewear”s top-line revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| SiBone | $200.93 million | 4.09 | -$18.90 million | ($0.34) | -54.47 |
| Innovative Eyewear | $3.41 million | 2.11 | -$7.59 million | ($1.29) | -0.65 |
Innovative Eyewear has lower revenue, but higher earnings than SiBone. SiBone is trading at a lower price-to-earnings ratio than Innovative Eyewear, indicating that it is currently the more affordable of the two stocks.
Analyst Ratings
This is a breakdown of current ratings for SiBone and Innovative Eyewear, as reported by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| SiBone | 1 | 0 | 6 | 0 | 2.71 |
| Innovative Eyewear | 1 | 1 | 0 | 0 | 1.50 |
SiBone currently has a consensus price target of $24.17, suggesting a potential upside of 30.49%. Given SiBone’s stronger consensus rating and higher possible upside, research analysts clearly believe SiBone is more favorable than Innovative Eyewear.
Profitability
This table compares SiBone and Innovative Eyewear’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| SiBone | -6.85% | -8.23% | -6.07% |
| Innovative Eyewear | -225.26% | -88.90% | -80.34% |
Institutional & Insider Ownership
98.1% of SiBone shares are held by institutional investors. Comparatively, 1.0% of Innovative Eyewear shares are held by institutional investors. 4.0% of SiBone shares are held by insiders. Comparatively, 1.7% of Innovative Eyewear shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.
Summary
SiBone beats Innovative Eyewear on 11 of the 14 factors compared between the two stocks.
About SiBone
SI-BONE, Inc., a medical device company, that operate to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers proprietary minimally invasive surgical implant system to address sacroiliac joint dysfunction and fusion, adult deformity and degeneration, and pelvic trauma; and implantable bone products. The company also provides iFuse-3D, a titanium implant that combines the triangular cross-section of the iFuse implant with the proprietary 3D-printed porous surface and fenestrated design; iFuse-TORQ, a set of 3D-printed threaded implants designed to treat pelvic trauma; and iFuse Bedrock Granite implant provides sacroiliac fusion and sacropelvic fixation as a foundational element for segmental spinal fusion. It markets its products primarily with a direct sales force, as well as through agents and resellers. SI-BONE, Inc. was incorporated in 2008 and is headquartered in Santa Clara, California.
About Innovative Eyewear
Innovative Eyewear, Inc. develops and sells smart eyeglasses and sunglasses. The company's flagship product is Lucyd Lyte glasses that enable the wearer to listen to music, take and make calls, and use voice assistants to perform various smartphone tasks hands-free. It also offers Vyrb, a social media application that enables the user to receive and send posts through Lucyd Lyte smart glasses with voice. In addition, the company launches an application, Lucyd app for iOS/Android users. It sells its products through various e-commerce, and retail store and distribution channels. Innovative Eyewear, Inc. has a license agreement with Lucyd Ltd. The company was incorporated in 2019 and is headquartered in North Miami, Florida. Innovative Eyewear, Inc. is a subsidiary of Lucyd Ltd.
Receive News & Ratings for SiBone Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SiBone and related companies with MarketBeat.com's FREE daily email newsletter.
